Edition:
United States

People: G1 Therapeutics Inc (GTHX.OQ)

GTHX.OQ on NASDAQ Stock Exchange Global Select Market

20.33USD
3:59pm EST
Change (% chg)

$0.34 (+1.70%)
Prev Close
$19.99
Open
$20.16
Day's High
$20.44
Day's Low
$19.71
Volume
53,542
Avg. Vol
131,507
52-wk High
$69.23
52-wk Low
$15.21

Muir, Glenn 

Mr. Glenn P. Muir is an Independent Director of G1 Therapeutics Inc. Mr. Muir has served as a member of our board of directors since September 2015. Mr. Muir also has served as a member of the board of directors of two publicly traded life science and medical device companies, Repligen Corporation since September 2015 and ReWalk Robotics Ltd. since July 2014, as well as privately held biotechnology company, RainDance Technologies, Inc. since August 2014. From September 2000 until May 2014, when he retired, Mr. Muir served as Executive Vice President, Finance and Administration of Hologic, Inc., or Hologic, a publicly traded manufacturer and supplier of medical products, and was Hologic’s Chief Financial Officer from 1992 until his May 2014 retirement. Mr. Muir served as the Controller of Hologic from October 1988 to 1992, including during its initial public offering in 1990. Mr. Muir served as a director of Hologic from 2001 through August 2013. Mr. Muir holds a B.B.A. with a major in accounting from the University of Massachusetts Amherst, an M.B.A. from the Harvard Graduate School of Business Administration and an M.Sc. in taxation from Bentley College Graduate School of Business. Mr. Muir is also a certified public accountant. We believe that Mr. Muir is qualified to serve as a member of our board of directors based on his experience in the life sciences, biotechnology and pharmaceutical industries and for his knowledge of financial and corporate development matters.

Basic Compensation

Total Annual Compensation, USD 236,655
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 236,655

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Seth Rudnick

257,523

Mark Velleca

738,217

Barclay Phillips

3,346,580

Rajesh Malik

688,715

Terry Murdock

1,152,080

Jay Strum

--
As Of  30 Dec 2017